Novartis tender offer for MorphoSys commences
The offer price corresponds to a premium of 142% on the volume-weighted average price during the last three months
The offer price corresponds to a premium of 142% on the volume-weighted average price during the last three months
A significant proportion of healthcare professionals still tend to favor branded drugs
Empowering Research, Enhancing Proficiency is the theme of this year’s Homoeopathic Symposium
Vericiguat works on a pathway not currently targeted by existing heart failure treatments
A game changing solution for the pharmaceutical industry
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
Abecma tripled progression-free survival compared to standard regimens in the Phase 3 KarMMa-3 trial
The company plans to add 1700 beds by FY27 through the organic route
Subscribe To Our Newsletter & Stay Updated